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ABSTRACT
Objectives: The health benefits of ‘drinking at least 8
glasses of water a day” in healthy individuals are
largely unproven. We aimed to examine the relationship
between total fluid and the sources of fluid
consumption, risk of rapid renal decline, cardiovascular
disease (CVD) mortality and all-cause mortality in
elderly women.
Design, setting and participants: We conducted a
longitudinal analysis of a population-based cohort
study of 1055 women aged ≥70 years residing in
Australia.
Main outcome measures: The associations between
total daily fluid intake (defined as total volume of
beverage excluding alcohol and milk) and the types of
fluid (water, black tea, coffee, milk and other fluids)
measured as cups per day and rapid renal decline, CVD
and all-cause mortality were assessed using adjusted
logistic and Cox regression analyses.
Results: Over a follow-up period of 10 years, 70
(6.6%) experienced rapid renal decline and 362
(34.4%) died, of which 142 (13.5%) deaths were
attributed to CVD. The median (IQR) intake of total
fluid was 10.4 (8.5–12.5) cups per day, with water
(median (IQR) 4 (2–6) cups per day) and black tea
(median (IQR) 3 (1–4) cups per day) being the most
frequent type of fluid consumed. Every cup per day
higher intake of black tea was associated with adjusted
HRs of 0.90 (95% CI 0.81 to 0.99) and 0.92 (95% CI
0.86 to 0.98) for CVD mortality and all-cause mortality,
respectively. There were no associations between black
tea intake and rapid renal decline, or between the
quantity or type of other fluids, including water intake,
and any clinical outcomes.
Conclusions: Habitual higher intake of black tea may
potentially improve long-term health outcomes,
independent of treating traditional CVD risk factors, but
validation of our study findings is essential.
INTRODUCTION
It is a widely held belief that adequate water
intake improves health outcomes, including
reducing the risk of chronic kidney disease
(CKD) and cardiovascular disease (CVD).1 2
The notion that high water intake could
potentially prevent the development of CKD
may, in part, be attributed to the inhibition
of arginine vasopressin (AVP), a hormone
known to be associated with glomerular
hyperfiltration and injury.3 In addition to
the effects on the glomerulus, high water
intake had been shown to ameliorate tubu-
lointerstitial injury in animal models, possibly
via inhibition of the profibrotic cytokine,
tumour necrosis factor-β.4 The association
between water or total fluid intake and the
risk of CVD is less clear; however, it is well
established that CVD risk is highly associated
with increasing severity of CKD.5–7 The
potential beneficial effects of water and
other fluid ingestion may, in part, be attribu-
ted to its effect on preventing pre-renal
states, thus preservation of kidney function.
Nevertheless, the exact association between
fluid intake and CKD is often difficult to
discern as dietary modifications, including
fluid restriction, could potentially follow a
diagnosis of CKD rather than precede it and
therefore evaluating CVD mortality and all-
cause mortality may be more appropriate
clinical outcomes.
Epidemiological studies of fluid intake
have reported conflicting findings. The
Adventist Health population cohort study,
Strengths and limitations of this study
▪ Completeness of the data set with long-term
outcomes.
▪ Evaluation of multiple clinically important
outcomes.
▪ Evaluation of habitual total fluid intake, with
complete estimation of all ‘liquid’ volumes.
▪ Accuracy in the measurement of exposure
factors including total fluid, water and tea intake.
▪ Potential for recall bias.
▪ Assessment of only baseline fluid consumption
but not change in fluid consumption over time.
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comprising 20 000 participants of both genders, sug-
gested that a higher intake of water (but excluding
other types of fluid) may be protective with a 40%
reduction in CVD mortality among those drinking over
five or more glasses of water per day compared with two
or fewer glasses per day. On the contrary, the
Netherlands cohort study of over 120 000 participants
aged 55–69 years of both genders did not find any
association between higher amounts of fluid con-
sumption and CVD or stroke mortality.8–10 With the
ongoing uncertainty of the beneficial health effects of
water and other fluid consumption, plus the known dif-
ferential effect of gender on CVD mortality, it is there-
fore crucial to examine the effects of the quantity of
daily total fluid consumption and the types of fluid
consumption on long-term health outcomes in gender-
specific populations.
We hypothesise that a higher intake of fluid consump-
tion, particularly water intake, is associated with
improved health outcomes in elderly women. The aims
of this analysis are twofold. First, to determine whether a
higher total daily fluid consumption is associated with a
slower renal function decline and reduction in 10-year
risk of CVD mortality and all-cause mortality; and
second, to evaluate the relative kidney-related CVD mor-
tality and all-cause mortality benefits of the different
types of fluid compositions, including water and other
beverages.
METHODS
Study population
One thousand five hundred women aged over 70 years,
with a majority from higher socioeconomic groups, were
recruited in 1998 in Perth, Western Australia to a 5-year
prospective randomised controlled trial of oral calcium
supplements (1.2 g of elemental calcium daily or match-
ing placebo from 1998 to 2003) to prevent osteoporotic
fractures. The details of the recruitment into this
Calcium Intake Fracture Outcome Study (CAIFOS;
Australian Clinical Trials Registry Registration Number:
ACTRN012607000055404) have been previously pub-
lished.11 At the completion of CAIFOS, participants
were followed in an observational study for a further
10 years (2003–2013). Our study data and analyses are
derived from these two associated studies. The Human
Research Ethics Committee of the Western Australian
Department of Health (DOHWA HREC) approved the
data linkage study (approval number #2009/24)
between CAIFOS and the follow-up observational study.
Baseline data
Details of baseline data collection have been previously
published.11 In brief, baseline medical history (including
diabetes, hypertension, smoking history) and medica-
tions were obtained from all participants, the latter veri-
fied with participants’ general practitioners where
required. Body mass index (BMI) measurements were
obtained at baseline and at 5 years postrandomisation
(1998 and 2003). At baseline, an average of three blood
pressure readings were measured and recorded after the
participants had been rested and seated for 5 min.
Socioeconomic status (SES) was assessed using relative
social advantage related to residential postcodes accord-
ing to the Australian Bureau of Statistics method.12 This
variable was divided into six categories: one being the
most disadvantaged and six being the least
disadvantaged.
Fluid assessment
A validated beverage intake questionnaire developed by
the Cancer Council Victoria (Melbourne, Australia),13
which quantified habitual beverage consumption during
the 12 months prior to study enrolment, was completed
by each participant in 2003. Total fluid consumption,
comprising water, black tea, coffee and other beverages
(eg, chocolate beverages, herbal tea, juices and sugar
beverages), excluding alcoholic beverages (including
beer, wine and spirits), was calculated. The exposure
study variable is cups (1 cup=250 mL) of total and types
of fluids (specifically water, black tea, coffee, milk and
other fluids) per day.
Biochemistry
Fasting blood samples were collected in 1998, 2003 and
2008 with sera stored in a −70°C freezer until analysis.
Creatinine measurements were performed using stored
sera with measurements of creatinine in 2003 and 2008
samples being available for 689 women (45.9%). Serum
creatinine was analysed using an isotope dilution mass
spectrometry traceable Jaffe kinetic assay for creatinine
on a Hitachi 917 analyser (Roche Diagnostics GmbH,
Mannheim, Germany). Estimated glomerular filtration
rate (eGFR) was derived using the creatinine-based
Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) equation.14
Assessment of clinical outcomes
Participants’ general practitioners verified their medical
histories and medications where possible, and were
coded using the International Classification of Primary
Care—Plus (ICPC-Plus) method.15 Prevalent CVD was
determined from hospital discharge data between 1980
and 1998 and were defined using diagnosis codes from
the International Classification of Diseases, Injuries
and Causes of Death Clinical Modification (ICD-9-CM,
390-459).16 Prevalent renal disease was collected
between 1980 and 1998 using ICD-9-CM 17. These codes
included glomerular diseases (ICD-9-CM codes 580–
583); renal tubulointerstitial diseases (ICD-9-CM codes
593.3–593.5, 593.7); renal failure (ICD-9-CM codes 584–
586) and hypertensive renal disease (ICD-9-CM code
403). The search for renal disease hospitalisations
included any diagnosis code.
The primary outcomes of the study were CVD mortal-
ity and all-cause mortality retrieved from the Western
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Australian Data Linkage System (WADLS) for each of
the study participants from 2003 to 2013. CVD mortality
was defined using primary death codes from ICD—the
International Statistical Classification of Diseases and
Related Health Problems, 10th Revision, Australian
Modification (ICD-10-AM), I00-I99.17 Text fields from
the death certificate were used to ascertain the cause(s)
of deaths where coded death data were not yet available
from the WADLS.
Statistical analysis
Baseline characteristics were expressed as mean and SD
or median and IQR for continuous variables or as
number and proportion for categorical variables.
Correlation between total fluid intake and alcohol
(gram/day (g/d)) was examined using Spearman’s coef-
ficient. Associations between fluid consumption and
change in eGFR (absolute change in eGFR between
2003 and 2008) and risk of rapid renal decline (defined
as reduction in eGFR of ≥3 mL/min/1.73 m2 annually
between 2003 and 2008) were assessed using unadjusted
and adjusted linear and logistic regression analyses,
respectively. Restricted cubic splines were modelled to
determine the linearity of the association between cups
of fluid consumption per day and mortality. Associations
between the total and types of fluids, CVD mortality and
all-cause mortality were examined using the Cox propor-
tional hazard regression models. The Cox models
included covariates recorded at baseline in 1998 (ie,
smoking history, SES, diabetes status, hypertension, sys-
tolic blood pressure, prevalent CVD, medications and
treatment code (calcium supplementation vs no calcium
supplementation)) and those recorded in 2003 (ie, fluid
status, age, BMI and eGFR). Selection of covariates for
inclusion in the multivariable-adjusted models were
undertaken in two analytical approaches: (1) covariates
with p<0.10 in the univariate models were selected (for
each outcome including change in eGFR, rapid renal
decline, CVD mortality and all-cause mortality), and (2)
the β coefficient of each of the independent covariate
and its association with each outcome in the univariate
analyses was evaluated. If the coefficient of the inde-
pendent covariate in the regression analyses changed by
more than 10%, it was considered to be a confounder,
and thus included in the final multivariable model. The
covariates that were included in the multivariable
models were selected from both analytical approaches.
Fluid status and treatment code were included in all
multivariable models irrespective of their associations in
the univariate models. p Values of <0.05 in two-tailed
testing were considered statistically significant. The pro-
portional hazard assumptions of all Cox models were
checked graphically by plotting the Schoenfield resi-
duals, but there was no evidence of departures from pro-
portional hazards for total and types of fluid intake. The
data were analysed using SPSS (V.15; SPSS, Chicago,
Illinois, USA) and STATA (V.11 StataCorp LP, College
Station, Texas, USA).
RESULTS
Baseline characteristics
The baseline characteristics of the 1055 participants are
shown in table 1. The mean age and burden of
comorbidities of the 445 participants who were excluded
(died between 1998 and 2003 or had missing data) were
similar to the included cohort (data not shown). Over a
follow-up time of 10 years between 2003 and 2013, 70
(6.6%) experienced rapid renal decline, and 362
(34.4%) died with 142 (13.5%) deaths attributed to
CVD (table 2). The annual CVD mortality rate in our
study cohort was 1346 deaths per 100 000 participants,
as compared with an annual CVD mortality rate of 979
deaths per 100 000 population for women aged 75–84
years reported to the Australian Institute of Health and
Welfare (AIHW; http://www.aihw.gov.au/cardiovascular-
disease/deaths/#dt).
Table 1 Baseline characteristics of participants
Cohort
(n=1055)
Patient characteristics
Age (years in 2003, mean±SD) 80.0±2.6
Body mass index at entry
(kg/m², mean±SD)
27.2±4.5
Body mass index at 60 m
(kg/m², mean±SD)
27.2±4.7
Systolic blood pressure
(mm Hg, mean±SD)
137.8±18.1
Diastolic blood pressure
(mm Hg, mean±SD)
73.1±10.9
Previous and current smokers (n, %) 375 (35.6)
Diabetes (n, %) 53 (5.0)
Prevalent acute/chronic kidney disease
(n, %)
0 (0.0)
Prevalent cardiovascular
disease (n, %)
227 (21.5)
Socioeconomic status (n, %)*
Top 10% most highly disadvantaged 42 (4.0)
Highly disadvantaged 126 (11.9)
High–medium disadvantaged 172 (16.3)
Medium–low disadvantaged 162 (15.4)
Low disadvantaged 213 (20.2)
Top 10% least disadvantaged 333 (31.6)
Medication use (n, %)
Aspirin 194 (18.4)
Statin 198 (18.8)
Treatment with calcium supplements (n, %) 536 (50.8)
Total and type of fluid composition in cups/day
(median, IQR)
Total fluid 10.4
(8.5–12.5)
Water 4 (2–6)
Black tea 3 (1–4)
Coffee 1 (0–2)
Milk 1.5 (0.8–1.5)
Other fluids 0.4 (0–1)
Data expressed as number (percentage), mean±SD or as median
(IQR).
*Missing socioeconomic status (n=7).
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The median (IQR) intake of total fluid was 10.4 (8.5–
12.5) cups per day, with water (median (IQR) 4 (2–6)
cups per day) and black tea (median (IQR) 3 (1–4)
cups per day) being the most frequent types of fluid
consumed. Almost 22% of participants had prevalent
CVD but no participants had prevalent CKD. Almost
70% of participants were from low-medium or low disad-
vantaged groups. There was no significant correlation
between total fluid intake and alcohol intake
(Spearman’s correlation −0.024, p=0.45).
Assessment of the relationship between total and types
of fluid intake and outcomes
The restricted cubic spline curves demonstrated that the
relationship between total fluid intake and both CVD
mortality and all-cause mortality was predominantly
linear. Similarly, the relationships between water, black
tea, coffee and other fluid intake and CVD mortality
and all-cause mortality were also linear (see online
supplementary figures S1 and S2).
Association between total fluid intake, 10-year CVD
mortality and all-cause mortality
There was no significant association between total fluid
intake and CVD or all-cause mortality in the unadjusted
and adjusted models. The unadjusted HRs for every cup
per day higher intake of total fluid for CVD mortality
and all-cause mortality were 0.96 (95% CI 0.91 to 1.05)
and 0.97 (95% CI 0.93 to 1.02), respectively, whereas the
adjusted HRs were 0.98 (95% CI 0.93 to 1.03) and 0.98
(95% CI 0.95 to 1.01), respectively. Other covariates
associated with increased hazards of CVD mortality and
all-cause mortality are shown in figure 1.
Association between fluid type, 10-year CVD mortality
and all-cause mortality
There was no association between water intake and risk
of CVD mortality or all-cause mortality. The unadjusted
HRs for every cup per day higher intake of water for
CVD mortality and all-cause mortality were 1.03 (95% CI
0.96 to 1.10) and 1.01 (95% CI 0.96 to 1.05), respect-
ively, whereas the adjusted HRs were 1.02 (95% CI 0.95
to 1.10) and 0.99 (95% CI 0.95 to 1.04), respectively. For
every cup per day higher intake of black tea, the
unadjusted HRs of CVD mortality and all-cause mortality
were 0.89 (95% CI 0.82 to 0.98) and 0.91 (95% CI 0.86
to 0.96), respectively. The adjusted HRs for every cup
per day higher intake of black tea for CVD mortality and
all-cause mortality were 0.90 (95% CI 0.81 to 0.99) and
0.92 (95% CI 0.86 to 0.98), respectively (figure 2).
There were no associations between coffee, milk and
other fluid types (excluding water, black tea and coffee)
intake and CVD mortality and all-cause mortality in the
unadjusted and adjusted models.
Association between total and type of fluid intake
and renal function decline
There was no association between total fluid intake and
odds of rapid renal decline, with unadjusted and
adjusted ORs of 1.02 (95% CI 0.95 to 1.10) and 1.04
(95% CI 0.96 to 1.12), respectively, for every cup per day
higher intake of total fluid. There was no association
between fluid type and rapid renal decline. The adjusted
OR for every cup per day higher intake of water and
black tea were 1.04 (95% CI 0.94 to 1.16) and 1.03 (95%
CI 0.90 to 1.18), respectively, adjusted for age, BMI,
hypertension and diabetes. Only diabetes was associated
with rapid renal decline with an adjusted OR of 3.38
(95% CI 1.47 to 7.75).
There was no association between total fluid intake
and change in eGFR. For every cup per day higher
intake of total fluid, there was a −0.12 mL/min/1.73 m2
(95% CI −0.38 to 0.13) and −0.18 mL/min/1.73 m2
(95% CI −0.42 to 0.07) reduction in 5-year eGFR,
respectively, in the unadjusted and adjusted models.
There was no association between fluid types and
Table 2 Clinical outcomes of participants
Cohort
(n=1055)
Outcomes
eGFR 2003 (n=1055; mL/min/1.73 m²,
mean±SD)
57.2±14.7
eGFR 2008 (n=689; mL/min/1.73 m²,
mean±SD)
55.4±16.1
Change eGFR 2003–2008 (mL/min/
1.73 m², mean±SD)
−2.3±10.5
Rapid renal decline 2003–2008 (n, %) 70 (6.6)
CVD deaths 2003–2013 (n, %) 142 (13.5)
Deaths 2003–2013 (n, %) 362 (34.3)
Data expressed as number (percentage) or as mean±SD.
CVD, cardiovascular disease; eGFR, estimated glomerular
filtration rate.
Figure 1 Forest plots showing the association between total
fluid consumption (every one cup higher intake per day), other
covariates and risk of CVD and all-cause mortality in the
adjusted Cox regression models. CVD, cardiovascular
disease; eGFR, estimated glomerular filtration rate.
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change in eGFR. Only the presence of diabetes was asso-
ciated with a decline in eGFR over 5 years of −6.28 mL/
min/1.73 m2 (95% CI −10.38 to −2.19).
DISCUSSION
The long-standing advice that drinking adequate
amounts of fluid to avoid dehydration may lead to an
improvement in health outcomes is currently not sup-
ported by consistent evidence. In this analysis of a pro-
spective contemporary population-based cohort of older
women over the age of 75 years, we have found no asso-
ciation between total fluid intake and 10-year hazards of
CVD mortality and all-cause mortality. However, higher
consumption of black tea was associated with a signifi-
cant reduction in CVD mortality and all-cause mortality,
independent of traditional CVD risk factors.
Similar to our study, another Australian prospective,
population-based cohort study of 3858 men and women
aged over 48 years found no association between total
fluid intake (from food and beverages excluding water)
and all-cause and CVD mortality.8 Similar findings
(water and other fluids excluding food were evaluated)
were corroborated in another large population-based
cohort of 120 852 men and women aged between 55
and 69 years recruited in the Netherlands.9 In contrast,
an inverse association between pure water intake
(excluding water from food) and risk of fatal coronary
artery disease (CAD) was shown in a large cohort of
20 297 men and women aged at least 38 years without
prevalent vascular disease or diabetes in the USA.
Compared with individuals who consumed two or less
glasses of water per day, those who consumed five or
more glasses of water per day had experienced over 30%
reduction in the risk of fatal CAD.10 The beneficial
effects of higher fluid intake in reducing the rates of vas-
cular events including recurrent stroke, myocardial
infarction or all-cause mortality were further shown in a
small prospective study of 465 patients with stroke.18 Our
study could not find an association between total fluid
intake and CVD mortality and all-cause mortality, even
though we established a best-fit linear relationship
between the continuous exposure factor, total fluid
intake and outcomes. The challenges in comparing and
interpreting the results from these epidemiological
studies include the vastly different populations with
varying characteristics, different eras, variations in the
definition of fluid consumption and dissimilar follow-up
periods. The basis of the suggestion that fluid intake is
associated with beneficial health outcomes has been
extrapolated from studies involving surrogate markers of
health outcomes and as such the evidence supporting
this assertion is weak. For example, mechanistic theories
suggest that adequate fluid intake to avoid dehydration
can lead to suppression of AVP and avoidance of adverse
physiological processes such as elevated plasma viscosity
and fibrinogen (putative surrogate markers of
CVD),19 20 which potentially may improve renal blood
flow and perfusion resulting in improved kidney func-
tion and health outcomes.3 To shed light on the incon-
sistent negative association between quantity of total
fluid consumption and important health outcomes, the
next logical step is to evaluate the association between
composition of beverage consumption and health
outcomes.
In our study, we have shown an independent inverse
association between consumption of black tea and CVD
mortality and all-cause mortality. Higher intake of black
tea was associated with a reduction in the relative
hazards of CVD mortality and all-cause mortality.
Nevertheless, our findings are in contrast to those of
other epidemiological studies where no consistent pat-
terns between types of beverages and clinical outcomes
could be found. In the US study, a higher intake of fluid
other than water (not examined by specific fluid types)
was associated with an increased risk of fatal CAD in
women but not in men, whereas the Netherlands study
suggests that the inverse relationship between tea intake
and CVD mortality was only apparent in men. A gender
differential in the risk of CVD mortality and stroke mor-
tality has been shown and although epidemiological
studies have suggested that traditional vascular risk
factors remain important in predicting mortality in men
and women, it does raise the question of whether differ-
ences in lifestyle, dietary or behavioural factors may con-
tribute to the gender disparity in CVD mortality.21
While the health benefits of black tea have been
attributed to the antioxidant and anti-inflammatory
properties of flavonoids (a major composition in tea—
100–300 mg per serving of tea),22–24 there may be other
beneficial components in black tea that remain unex-
plored. In a survey of US adults, women were more
Figure 2 Forest plots showing the association between
types of fluid consumption (every one cup higher intake per
day), including water, black tea, coffee, milk and other fluids
and risk of CVD and all-cause mortality, adjusted for age,
blood pressure, prevalent CVD, diabetes and eGFR. CVD,
cardiovascular disease; eGFR, estimated glomerular filtration
rate.
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likely to consume a greater amount of flavonoids in
their diet compared with men and the greatest source of
intake of flavonoids was from tea.25 Of note, the flavon-
oid content in non-herbal tea depends on the strength,
type of tea (particularly black tea) and the process of
oxidisation. Furthermore, there are other food and bev-
erage sources of flavonoids such as chocolate, nuts and
red wine that may have modified the association
between black tea and outcomes. The finding of a sig-
nificant inverse association between tea consumption
and CVD and all-cause mortality in women with CKD is
intriguing but requires validation in other cohorts.
Finally, we have previously shown that increased con-
sumption of proanthocyanidins, a class of flavonoids, was
associated with improved kidney function and reduced
risk of kidney disease-related clinical events but did not
address the association of renal function decline.26 In
this study, there was no association between total fluid,
water or black tea consumption and eGFR decline or
risk of rapid renal decline, findings that have been con-
tradicted in other large cohort studies. A cross-sectional
analysis of 3427 adults with a mean age of 46 years from
the National Health and Nutrition Examination Survey
(NHANES) showed that CKD, defined as eGFR between
30 and 60 mL/min/1.73 m2, was associated with a lower
intake of plain water of <2 L/day with adjusted OR of
2.36 (95% CI 1.10 to 5.06), compared with those with a
higher water intake of >4.3 L/day.27 A similar protective
effect between high fluid intake and development of
CKD has also been shown in a cohort of older men and
women with mean ages of 65 years.28 However, these
studies defined CKD using a single time-point eGFR in
the absence of other markers of CKD such as albumin-
uria. This association needs to be examined in other
population cohorts using other markers of CKD and
change in eGFR before this assertion can be
substantiated.
Our study has several strengths and limitations. The
prospective nature and completeness of the data set
suggest that selection and ascertainment biases between
the exposure factor and outcomes are minimised. The
analytical data on fluid intake were calculated before
examination of the relation to clinical outcome data
and were subjected to meticulous covariate analysis in
an attempt to identify important collinearity that may
have accounted for the observed associations.
Identification of causality is limited by the potential for
recall bias, the complexity of estimating total fluid
intake and the variability of the composition of the
various beverages. Our analysis only focused on baseline
fluid consumption but not change in fluid consumption
over time, which may have modified our result findings.
In addition, fluid derived from dietary consumption,
which is likely to account for a small percentage of
overall daily fluid intake, amount/intensity of exercise
and energy expenditure were not included in this study
because of the uncertainty over the accuracy of this
information but could have modified the association
between fluid intake and outcomes. In addition, we had
excluded alcohol in the estimation of total fluid intake
because epidemiological studies have shown an inde-
pendent association between alcohol intake and health
outcomes (including CVD mortality).29 However,
despite these limitations, the association between
volume of black tea consumption and mortality remains
significant even after adjustment for other factors.
Future studies will determine the generalisability of our
results to a wider population, including men and
younger individuals.
CONCLUSION
We found no association between the amount or type of
daily fluid intake and renal function decline. However,
an inverse linear relationship between the daily amount
of black tea ingested and long-term hazards of CVD
mortality and all-cause mortality was found in a cohort
of elderly women. External validation of our findings in
men and women of varying ages is required to establish
the true clinical significance of black tea intake.
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